dr. dimopoulos on the goal of the aspen trial in waldenström macroglobulinemia
Published 3 years ago • 105 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:12
dr. dimopoulos on the utility of zanubrutinib in waldenström macroglobulinemia
-
3:57
professor dimopoulos - what is waldenström’s macroglobulinemia & how is it diagnosed?
-
52:45
current treatment options - stephen ansell, md
-
2:28
meet the pardee cardiologists | martin sullivan, md, facc
-
16:39
physician spotlight: ben d. albert, md
-
4:16
aha 2017 | stemi accelerator-2 study
-
16:13
aspen neuroscience
-
2:18
eva feldman, md, phd
-
3:26
cardiology countdown | top 3 clinical trials of 2011
-
2:39
american football and long-term mortality: q&a with atheendar venkataramani
-
15:27
physician spotlight: mark corkins, md, cnsc, faspen, agaf, faap
-
3:12
complete study results
-
1:04
leslie aldrich, md - video profile
-
0:59
cardiac oncology | amber boler, md, facc | general cardiologist
-
4:13
aha 2014 | primary endpoint from dapt
-
3:20
dr. devore on the extension study of the pioneer-hf trial
-
0:53
are there clues that doctors rely on that will point them in the right direction of a diagnosis?
-
3:58
acc.10 | navigator trial